Oncosil Medical Ltd (ASX:OSL) fell 2.8% during mid-day trading on Monday . The company traded as low as A$0.17 ($0.12) and last traded at A$0.18 ($0.12), 2,716,805 shares traded hands during mid-day trading. The stock had previously closed at A$0.18 ($0.13).
The company has a market cap of $97.76 million and a PE ratio of -11.07. The company has a quick ratio of 11.59, a current ratio of 11.69 and a debt-to-equity ratio of 0.45. The business has a 50-day simple moving average of A$0.17 and a 200-day simple moving average of A$0.13.
Oncosil Medical Company Profile (ASX:OSL)
OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for cancer in Australia. Its lead product is OncoSil, a brachytherapy device comprising OncoSil Phosphorous-32 Microparticles and OncoSil Diluent, which implants a pre-determined dose of beta radiation emitting isotope directly into cancerous tissue for the treatment of pancreatic and liver cancer.